IDEANOMICS INC(NASDAQ:IDEX) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 0 out of 10 to IDEX. IDEX was compared to 129 industry peers in the Machinery industry. Both the profitability and financial health of IDEX have multiple concerns. IDEX is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IDEX has reported negative net income.

IDEX had a negative operating cash flow in the past year.

IDEX had negative earnings in each of the past 5 years.

In the past 5 years IDEX always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -191.90%, IDEX is doing worse than 97.69% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-191.9%
ROE	N/A
ROIC	N/A

ROA(3y)-117.79%

ROA(5y)-94.59%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IDEX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IDEX does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, IDEX has more shares outstanding

Compared to 5 years ago, IDEX has more shares outstanding

The debt/assets ratio for IDEX is higher compared to a year ago.

2.2 Solvency

IDEX has an Altman-Z score of -16.65. This is a bad value and indicates that IDEX is not financially healthy and even has some risk of bankruptcy.

IDEX's Altman-Z score of -16.65 is on the low side compared to the rest of the industry. IDEX is outperformed by 96.92% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-16.65

ROIC/WACCN/A

WACC6.47%

2.3 Liquidity

IDEX has a Current Ratio of 0.28. This is a bad value and indicates that IDEX is not financially healthy enough and could expect problems in meeting its short term obligations.

The Current ratio of IDEX (0.28) is worse than 98.46% of its industry peers.

A Quick Ratio of 0.11 indicates that IDEX may have some problems paying its short term obligations.

IDEX has a Quick ratio of 0.11. This is amonst the worse of the industry: IDEX underperforms 97.69% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.28
Quick Ratio	0.11

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.75% over the past year.

Looking at the last year, IDEX shows a very negative growth in Revenue. The Revenue has decreased by -65.32% in the last year.

The Revenue for IDEX have been decreasing by -47.23% on average. This is quite bad

EPS 1Y (TTM)64.75%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%90.11%

Revenue 1Y (TTM)-65.32%

Revenue growth 3Y-16.76%

Revenue growth 5Y-47.23%

Sales Q2Q%-77.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y58.33%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year74.39%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IDEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IDEX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IDEX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

IDEANOMICS INC

NASDAQ:IDEX (7/10/2024, 8:07:35 PM)

After market: 0.634 -0.25 (-27.95%)

0.88

-0.04 (-4.36%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)03-14 2024-03-14/amc

Earnings (Next)08-02 2024-08-02

Inst Owners0.12%

Inst Owner Change-74.46%

Ins Owners52.88%

Ins Owner Change0%

Market Cap17.66M

Analysts43.33

Price Target1.02 (15.91%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-98.19%

Min Revenue beat(2)-99.37%

Max Revenue beat(2)-97.01%

Revenue beat(4)0

Avg Revenue beat(4)-93.6%

Min Revenue beat(4)-99.37%

Max Revenue beat(4)-87.75%

Revenue beat(8)0

Avg Revenue beat(8)-83.55%

Revenue beat(12)1

Avg Revenue beat(12)-58.6%

Revenue beat(16)1

Avg Revenue beat(16)-44.32%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.96
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-21.43

EYN/A

EPS(NY)-0.1

Fwd EYN/A

FCF(TTM)-2.62

FCFYN/A

OCF(TTM)-2.62

OCFYN/A

SpS0.92

BVpS-0.71

TBVpS-3.67

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-191.9%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-117.79%

ROA(5y)-94.59%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score2

Asset Turnover0.16

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	0%
Cap/Sales	0%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.28
Quick Ratio	0.11
Altman-Z	-16.65

F-Score2

WACC6.47%

ROIC/WACCN/A

Cap/Depr(3y)67.58%

Cap/Depr(5y)57.59%

Cap/Sales(3y)4.51%

Cap/Sales(5y)3.66%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)64.75%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%90.11%

EPS Next Y58.33%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-65.32%

Revenue growth 3Y-16.76%

Revenue growth 5Y-47.23%

Sales Q2Q%-77.68%

Revenue Next Year74.39%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y30.96%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year144.14%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y61.81%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y59.49%

OCF growth 3YN/A

OCF growth 5YN/A

IDEANOMICS INC (IDEX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens